Evidence map›Paper›PMID 34925689›Full record

ArticleOxidative medicine and cellular longevity2021

The Differences in the Levels of Oxidative Status Marker and Soluble CD95 in Patients with Moderate to Severe COPD during an Exacerbation and a Stable Period.

Svetlana Soodaeva, Nailya Kubysheva, Igor Klimanov, Alexey Shutov, Tatyana Eliseeva, Viktor Novikov, Klavdiya Kontorshchikova, Dmitry Novikov, Ildar Batyrshin

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Svetlana SoodaevaPulmonology Scientific Research Institute under FMBA of Russia, Orekhovyy Bul'var 28, Moscow 115682, Russia.ORCID https://orcid.org/0000-0001-6453-0017
Nailya KubyshevaKazan Federal University, Kremlyovskaya St, 18, Kazan 420000, Russia.ORCID https://orcid.org/0000-0002-5582-5814
Igor KlimanovPulmonology Scientific Research Institute under FMBA of Russia, Orekhovyy Bul'var 28, Moscow 115682, Russia.ORCID https://orcid.org/0000-0001-8593-1098
Alexey ShutovPulmonology Scientific Research Institute under FMBA of Russia, Orekhovyy Bul'var 28, Moscow 115682, Russia.ORCID https://orcid.org/0000-0002-3588-8957
Tatyana EliseevaFederal State Budgetary Educational Institution of Higher Education Privolzhsky Research Medical University, Minin and Pozharsky Square 10/1, Nizhny Novgorod 603005, Russia.ORCID https://orcid.org/0000-0002-1769-3670
Viktor NovikovN.I.Lobachevsky Nizhny Novgorod National Research State University, Gagarina Avenue 23, Nizhny Novgorod 603950, Russia.ORCID https://orcid.org/0000-0002-2449-7213
Klavdiya KontorshchikovaFederal State Budgetary Educational Institution of Higher Education Privolzhsky Research Medical University, Minin and Pozharsky Square 10/1, Nizhny Novgorod 603005, Russia.ORCID https://orcid.org/0000-0001-8345-9359
Dmitry NovikovN.I.Lobachevsky Nizhny Novgorod National Research State University, Gagarina Avenue 23, Nizhny Novgorod 603950, Russia.ORCID https://orcid.org/0000-0001-7049-6935
Ildar BatyrshinInstituto Politécnico Nacional, Centro de Investigación en Computación (CIC-IPN), Av. Juan de Dios Bátiz, Esq. Miguel Othón de Mendizábal S/N, Gustavo A. Madero, 07738 Mexico City, Mexico.ORCID https://orcid.org/0000-0003-0241-7902
State Research Institute of Highly Pure Biopreparations · RUNizhniy Novgorod Research Institute of Epidemiology and Microbiology named after Academician I.N. Blokhina · RUPrivolzhsky Research Medical University · RUInstituto Politécnico Nacional · MXKazan Federal University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studying the features of changes in markers of oxidative stress (OS) and inflammation indicators in COPD patients depending on the degree of bronchial obstruction is one of the priority directions for improving the prognosis and monitoring of the course of this pathology. We conducted a comparative investigation of changes in markers of OS and apoptosis at the systemic and local levels in patients with moderate to severe COPD during exacerbation and stable phase. 105 patients with COPD aged 46-67 and 21 healthy nonsmoking volunteers comparable in age were examined. COPD patients were divided into four groups: moderate COPD (GOLDII) during the exacerbation (GOLDIIex,

Indexed as

Lipid PeroxidationOxidative StressSeverity of Illness IndexApoptosisBreath TestsCase-Control Studiesfas ReceptorFemaleHumansMaleMiddle AgedPulmonary Disease, Chronic ObstructiveFAS protein, humanfas Receptor

Identifiers

PMID34925689
PMCPMC8677381
OpenAlexW4200547787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.